Generic Biosimilar Medicines Association

Making Medicines Affordable

Home
About GBMA
- Contact us
- GBMA Members
- Guiding principles
- Code of Practice
  - Code Complaint Committee
  - Event Reporting
    - Educational Events
    - Non-Price Benefit Reports
  - Annual Review
    - 2011
    - 2012
    - 2013
    - 2014
    - 2015
    - 2016
    - 2017
    - 2018
    - 2019
    - 2020
  - Lodging a complaint
- Media Enquiries
- Our Objectives
- Links
Advocacy
Generics
Biosimilars
Topics
News
- News 2021
- News 2020
- News 2019
- News 2018
- News 2017
- News 2016
- News 2015
- News 2014
GBMA Education
COVID-19 Virus
- COVID-19 Virus: The Facts

You are here: Home / Biosimilars / GBMA Position on Biosimilars / Key Figures on Biosimilars

Key Figures on Biosimilars

Patients and economy to benefit from ‘medicine manufacturing’ roadmap

March 2, 2021

2 March 2021 Canberra, ACT Australia’s peak body for affordable medicines, today welcomed the Government’s launch of … More...

Active Ingredient Prescribing – a game changer for patients: Prescription reforms to further support patient safety

February 1, 2021

1 February 2021 Canberra, ACT Canberra: Australia’s patients will be the … More...

Announcement of Independent Chair

December 9, 2020

9 December 2020 Canberra, ACT Global health policy powerhouse, Jane Halton … More…

© 2021 Generic Medicines Industry Association Pty Ltd | Site Map | Contact Us